HRTX – heron therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Heron Therapeutics, Inc. (NASDAQ: HRTX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Heron Therapeutics, Inc. (NASDAQ: HRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Heron Therapeutics Inc (HRTX) Q3 2024 Earnings Call Highlights: Strategic Initiatives Drive ... [Yahoo! Finance]
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Form SC 13G HERON THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
Form 10-Q HERON THERAPEUTICS, INC. For: Sep 30
Form 8-K HERON THERAPEUTICS, INC. For: Nov 12
Form SC 13G HERON THERAPEUTICS, INC. Filed by: BlackRock, Inc.
Form 4 HERON THERAPEUTICS, INC. For: Nov 04 Filed by: Kaseta Michael
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.